| Unique ID issued by UMIN | UMIN000054809 |
|---|---|
| Receipt number | R000062509 |
| Scientific Title | Non-invasive identification of high-risk plaques in non-culprit lesions of acute coronary syndrome |
| Date of disclosure of the study information | 2024/06/30 |
| Last modified on | 2024/06/28 15:32:10 |
Non-invasive identification of high-risk plaques in non-culprit lesions of acute coronary syndrome
Non-invasive identification of high-risk plaques in non-culprit lesions of acute coronary syndrome
Non-invasive identification of high-risk plaques in non-culprit lesions of acute coronary syndrome
Non-invasive identification of high-risk plaques in non-culprit lesions of acute coronary syndrome
| Japan |
acute coronary syndrome
| Cardiology |
Others
NO
The objectives of the study was to determine whether delta-FFR-CT and Coronary computed tomographic angiography(CCTA) measurements could more easily differentiate lesions with maxLCBI4mm greater than 400 by near-infrared spectroscopy intravascular ultrasound (NIRS-IVUS) in non-culprit lesions of ACS.
Bio-availability
Correlation between maxLCBI4mm values as indicated by NIRS-IVUS and plaque density,remodeling index, presence of microcalcification and napkin ring sign as assessed by CCTA and difference between FFR-CT proximal and distal to the stenosis (delta-FFR-CT) in non-responsive lesions
Observational
| 20 | years-old | <= |
| 90 | years-old | >= |
Male and Female
(1) patients were admitted with ACS (ST-segment elevation myocardial infarction, non-ST-segment elevation myocardial infarction, and unstable angina pectoris); (2) intermediate stenosis in non-culprit lesions on coronary angiography or CCTA; (3) NIRS-IVUS evaluation for intermediate stenosis after percutaneous coronary intervention; and (4) each non-culprit lesion was evaluated using CCTA and FFRCT performed within a duration of 14 days between CT and percutaneous coronary intervention.
(1) chronic kidney disease as shown by an estimated glomerular filtration rate <30 ml/min/1.73 m2; (2) presentation with hemodynamic instability; (3) severe valvular heart diseases, (4) left main trunk lesions; (5) lesions that could not be evaluated by NIRS-IVUS for any reason (e.g., tortuous vessels, severe stenosis, and calcification that made catheter passage difficult); and (6) poor image quality that resulted in an inability to perform CCTA or NIRS-IVUS analysis.
100
| 1st name | Masafumi |
| Middle name | |
| Last name | Ueno |
Kindai University Faculty of Medicine
Division of Cardiology
589-8511
377-2, Ohno-Higashi, Osakasayama, Osaka, Japan
81-72-366-0221
mueno@med.kindai.ac.jp
| 1st name | Kazuyoshi |
| Middle name | |
| Last name | Kakehi |
Kindai University Faculty of Medicine
Division of Cardiology
589-8511
377-2, Ohno-Higashi, Osakasayama, Osaka, Japan
81-72-366-0221
kakehi324@yahoo.co.jp
Kindai University Faculty of Medicine
Kindai University Faculty of Medicine
Self funding
Kindai University Faculty of Medicine
377-2, Ohno-Higashi, Osakasayama, Osaka, Japan
81-72-366-0221
kakehi324@yahoo.co.jp
NO
| 2024 | Year | 06 | Month | 30 | Day |
Unpublished
Open public recruiting
| 2021 | Year | 10 | Month | 01 | Day |
| 2021 | Year | 11 | Month | 18 | Day |
| 2023 | Year | 12 | Month | 01 | Day |
| 2026 | Year | 12 | Month | 31 | Day |
After the protocol has been approved by the Director, case enrollment will begin until December 2025 (the period of accumulation may be changed depending on the status of case enrollment). The study period, including the follow-up period, will be until the end of December 2026.
| 2024 | Year | 06 | Month | 28 | Day |
| 2024 | Year | 06 | Month | 28 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000062509